"Amphotericin B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela.
| Descriptor ID |
D000666
|
| MeSH Number(s) |
D02.540.576.500.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Amphotericin B".
Below are MeSH descriptors whose meaning is more specific than "Amphotericin B".
This graph shows the total number of publications written about "Amphotericin B" by people in this website by year, and whether "Amphotericin B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 2003 | 2 | 1 | 3 |
| 2004 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 0 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amphotericin B" by people in Profiles.
-
Liu H, Rivnay B, Avery K, Myung JH, Kozak D, Landrau N, Nivorozhkin A, Ashraf M, Yoon S. Optimization of the manufacturing process of a complex amphotericin B liposomal formulation using quality by design approach. Int J Pharm. 2020 Jul 30; 585:119473.
-
Choe YJ, Blatt DB, Yalcindag A, Geffert SF, Bobenchik AM, Michelow IC. Cryptococcus albidus Fungemia in an Immunosuppressed Child: Case Report and Systematic Literature Review. J Pediatric Infect Dis Soc. 2020 Feb 28; 9(1):100-105.
-
Martins TAF, Barbosa VS, Almeida GG, Antonelli LRDV, Tafuri WL, Mosser DM, Gon?alves R. Monocyte subpopulations as important biomarkers of resistence and susceptibility during experimental infection with Leishmania (Leishmania) major. Biomed Pharmacother. 2018 Nov; 107:1530-1539.
-
Agudelo CA, Mu?oz C, Ram?rez A, Tob?n AM, de Bedout Bact C, Cano LE, Restrepo A. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole. Rev Iberoam Micol. 2015 Oct-Dec; 32(4):214-20.
-
Di Pentima MC, Chan S, Powell J, Napoli JA, Walter AW, Walsh TJ. Topical amphotericin B in combination with standard therapy for severe necrotizing skin and soft-tissue mucormycosis in an infant with bilineal leukemia: case report and review. J Pediatr Hematol Oncol. 2014 Oct; 36(7):e468-70.
-
Lin TY, Chin CR, Everitt AR, Clare S, Perreira JM, Savidis G, Aker AM, John SP, Sarlah D, Carreira EM, Elledge SJ, Kellam P, Brass AL. Amphotericin B increases influenza A virus infection by preventing IFITM3-mediated restriction. Cell Rep. 2013 Nov 27; 5(4):895-908.
-
Agudelo CA, Restrepo CA, Molina DA, Tob?n AM, Kauffman CA, Murillo C, Restrepo A. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg. 2012 Dec; 87(6):1094-8.
-
Theodoropoulos N, Angarone M. Photo quiz. Lip lesion in a solid organ transplant recipient. Clin Infect Dis. 2012 May; 54(9):1332, 1373-4.
-
Levitz SM, Shoham S, Cleary JD. Toll-like receptor 4 polymorphisms and aspergillosis. N Engl J Med. 2009 Feb 05; 360(6):634; author reply 635-6.
-
Hadley S, Huckabee C, Pappas PG, Daly J, Rabkin J, Kauffman CA, Merion RM, Karchmer AW. Outcomes of antifungal prophylaxis in high-risk liver transplant recipients. Transpl Infect Dis. 2009 Feb; 11(1):40-8.